White House Schedules More Meetings On Cannabis Product Enforcement Policy From FDA For This Week
The White House has scheduled four meetings this week with cannabis industry and research stakeholders to discuss a proposed FDA enforcement policy for CBD products. The Office of Information and Regulatory Affairs (OIRA) under the Office of Management and Budget (OMB) announced it will review unpublished FDA guidance on cannabis product enforcement.
Filed under Meeting in THC Minnesota's coverage of Minnesota's cannabis and hemp market.
Mentioned
Source Attribution
This summary was compiled from information published by Marijuana Moment. All facts and statements reflect the original source material. For complete details, refer to the original publication.
View Original Source →Related Updates
White House Schedules Meeting On Cannabis Products Enforcement Policy For Next Week
White House schedules cannabis enforcement meeting (Newsletter: March 27, 2026)
FBI Says Agents Can Invest And Work In Hemp Companies But Not Marijuana Industry, Newly Declassified Memo Shows
Ellison and other AGs push for ban on ‘intoxicating hemp-derived’ THC products
Federal hemp ban leaves Minnesota THC sellers in limbo
GOP Congressman Files Bill To Delay Federal Hemp Ban For Two More Years As Trump Calls For CBD Access
Stay current on Minnesota cannabis
Browse more meeting updates, the full news feed, or the Minnesota cannabis timeline. Compare products across licensed dispensaries and read our consumer guides.